CNC stock forecast, quote, news & analysis
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges... Show more
Centene Corporation (CNC) Stock Analysis: Navigating Medicaid Membership Shifts
Key Takeaways
- Centene's shares have stabilized in the low $40s range after a sharp decline from 52-week highs near $64, reflecting ongoing pressures in managed care.
- Q1 2026 earnings, due April 28, face headwinds from declining memberships and elevated medical costs, with EPS expected to drop 36% year-over-year.
- Company guides for 2026 adjusted diluted EPS above $3.00, signaling margin recovery via improved health benefits ratio (HBR, medical costs as percentage of premiums).
- Analyst consensus leans Hold with average price target around $43-$49, amid recent upgrades like Truist to $49 Buy.
- Low forward P/E of about 14x highlights potential value if cost controls succeed.
Current Market Snapshot
In recent weeks, Centene Corporation (CNC) stock has traded within a narrow band in the low $40s, marking a modest stabilization following broader sector volatility in managed healthcare. The shares reflect investor caution amid rising medical utilization trends and membership adjustments in key government programs like Medicaid. Despite year-to-date gains, the stock remains well below its 52-week peak, pressured by profitability challenges exposed in prior results. Trading volume has aligned with averages, signaling steady interest as the market awaits updates on cost management and segment performance. Broader healthcare dynamics, including regulatory scrutiny and reimbursement rates, continue to shape sentiment.
Trending AI Robots
Tickeron's Trending AI Robots page showcases the top 25 performers curated from over 350 AI trading bots that analyze and trade thousands of tickers across stocks, ETFs, and crypto. These bots employ diverse strategies, including pattern recognition, momentum trading, and corridor take-profit/stop-loss exits (e.g., TP 3%/SL 2%), operating on timeframes from 5 minutes to 60 minutes. Standouts feature annualized returns up to 167%, win rates ranging 48% to 88% (averaging around 61%), and profit factors from 1.5 to 11.7 (average ~2.5). Popular themes include semiconductors (e.g., NVDA, LRCX bots with 100%+ returns), leveraged ETFs, and multi-ticker sector plays like energy or industrials. While none currently spotlight CNC, these tools adapt to market conditions, offering investors automated insights for volatile environments. Explore the page to identify bots matching your risk profile and timeframe.
Recent Developments Driving CNC Price Action
Centene Corporation (CNC), a leading managed care provider focused on Medicaid, Medicare, and commercial health plans, has seen its stock consolidate amid anticipation for Q1 2026 earnings on April 28. Expectations center on declining memberships, particularly in Medicaid following redeterminations, alongside elevated medical costs that pressured 2025 results. The company reported a full-year 2025 net loss, despite revenue growth to $176 billion, due to a high HBR of 91.9%. Shares dipped initially post-earnings in February but have since rebounded modestly, gaining about 1.8% in recent sessions to around $41.82, buoyed by reaffirmations of 2026 guidance.
Analyst activity has provided mixed support. Jefferies raised its price target to $39 from $37 while maintaining a Hold rating on April 20, citing ongoing cost pressures. Truist Financial lifted its target to $49 with a Buy, following positive management meetings. Consensus remains Hold, with an average target of $43.47, reflecting cautious optimism on recovery potential versus near-term risks like Q1 EPS decline of 36%.
Non-financial news highlights corporate responsibility: The Centene Foundation invested $34.9 million in 2025 for community health and education, while Superior HealthPlan employees logged over 3,000 volunteer hours in Texas. These initiatives underscore social impact but have limited direct bearing on price. Macro factors, including potential Medicaid funding changes and healthcare inflation, amplify scrutiny on operational efficiency. No major M&A (mergers and acquisitions), regulatory shifts, or partnerships emerged in the period, keeping focus on earnings delivery. Price stability suggests investors are pricing in guided improvements while hedging membership and utilization risks.
2026 Outlook and Key Factors to Monitor
Centene's 2026 guidance points to adjusted diluted EPS exceeding $3.00, a potential 40% plus improvement from 2025's trough, driven by HBR contraction to 90.9%-91.7%. Commercial segment gains and Medicaid stabilization are pivotal, alongside cost discipline in pharmacy and administrative expenses. Investors should track membership trends post-redeterminations, medical loss ratio trends, and reimbursement dynamics under evolving government policies. Competitive positioning in Marketplace and Medicare Advantage, plus technology investments for utilization management, offer growth levers. Risks include regulatory reforms, litigation resolutions, and macroeconomic pressures on premiums. Balanced monitoring of quarterly guidance updates and segment metrics will be essential as the company aims to restore profitability amid industry consolidation.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
CNC's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CNC turned positive on April 02, 2026. Looking at past instances where CNC's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on April 06, 2026. You may want to consider a long position or call options on CNC as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CNC moved above its 50-day moving average on April 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNC crossed bullishly above the 50-day moving average on April 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CNC advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 195 cases where CNC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CNC broke above its upper Bollinger Band on April 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.267) is normal, around the industry mean (3.678). P/E Ratio (9.063) is within average values for comparable stocks, (39.736). Projected Growth (PEG Ratio) (1.053) is also within normal values, averaging (1.150). CNC's Dividend Yield (0.000) is considerably lower than the industry average of (0.022). P/S Ratio (0.137) is also within normal values, averaging (0.649).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a multi-line healthcare enterprise
Industry ManagedHealthCare